Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of COVID-19 on Patients Treated With Autologous Hematopoietic Stem Cell Transplantation in Sweden - a Retrospective Cohort Study

NCT04760184 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

NCT NCT04760184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04760184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of COVID-19 on Patients Treated With Autologous Hematopoietic Stem Cell Transplantation in Sweden - a Retrospective Cohort Study
Lead sponsor
Uppsala University
Phase
Observational
Overall status
Completed
Start date
April 1, 2021
Completion date
December 31, 2021
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, hematologic neoplasms, malignant lymphoma, myeloma multiple, stem cell transplant complications